학술논문

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group
Document Type
Journal
Source
ANNALS OF HEMATOLOGY; SEP 2005, 84 9, p557-p564, 8p.
Subject
Language
English
ISSN
09395555